Review
Accepted on 18 Apr 2025
Curcumin: A potential anti-photoaging agent
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1559032
Type at least 3 characters
26,231 articles
Original Research
Accepted on 18 Apr 2025
Beta-boswellic Acid Facilitates Diabetic Wound Healing by Targeting STAT3 and Inhibiting Ferroptosis in Fibroblasts
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1578625
Original Research
Accepted on 18 Apr 2025
Adverse drug events associated with Insulin glargine: a real-world pharmacovigilance study based on the FAERS database
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1563238
Review
Accepted on 18 Apr 2025
The research progress on radionuclides in osteoporosis diagnosis and drug efficacy monitoring
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1594903
Original Research
Accepted on 18 Apr 2025
Sulindac exhibits anti-proliferative and anti-invasive effects and enhances the sensitivity to paclitaxel in ovarian cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1520771
Original Research
Accepted on 18 Apr 2025
Gen-miR-5 Derived from Gentianella acuta Inhibits PFKP to Prevent Fibroblast Activation and Alleviate Myocardial Fibrosis
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1578877
Review
Accepted on 18 Apr 2025
Gut Microbiota: A New Target for the Prevention and Treatment of Insomnia Using Chinese Herbal Medicines and Their Active Components
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1572007
Review
Accepted on 18 Apr 2025
Pharmacological Potential of Natural Chalcones: A Recent Studies and Future Perspective
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1570385
Original Research
Accepted on 18 Apr 2025
Harmine derivative B-9-3 inhibits non-small cell lung cancer via the VEGFA/PI3K/AKT pathway
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1526952
- 146 views
Original Research
Accepted on 18 Apr 2025
Bioactive Lipids and Allelopathic Potential of the Invasive Plant Heracleum sosnowskyi: Insights into Its Fatty Acid Composition, Antimicrobial and Cytotoxic Effects
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1582694
Original Research
Accepted on 18 Apr 2025
Serum 25(OH)D and plasma fatty acids on breast and gastric tumors: A cross-sectional study in Northeast China
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1567568
Editorial
Accepted on 18 Apr 2025
Advancements in Sex-Specific Tumor Heterogeneity
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1598740
General Commentary
Accepted on 18 Apr 2025
Commentary: Triclabendazole Induces Pyroptosis by Activating Caspase-3 to Cleave GSDME in Breast Cancer Cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1583920
Case Report
Accepted on 18 Apr 2025
Crizotinib for ROS1 SCLC Case report: Durable response of immuno-chemotherapy targeting a rare ROS1 fusion-positive extensive-stage SCLC patient after primary resistance to crizotinib
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1522542
Original Research
Accepted on 17 Apr 2025
Apigenin promotes melanogenesis and melanosome transport through the c-KIT/Raf-1/MAPK/CREB pathway in HEMCs
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1572878
- 130 views
Original Research
Accepted on 17 Apr 2025
Resveratrol and N-acetylcystein reduce hepatic steatosis but enhance initiation and progression of hepatocellular carcinoma by inhibiting GST-pi-MAPK axis in mice
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1574039
- 118 views